Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Shandong Weigao Orthopaedic Device Co EV-to-FCF?
Shandong Weigao Orthopaedic Device CoSHSE:688161 -4.47%75 EV-to-FCF is 19.07 as of Jul. 17, 2026, which is 49% below its 10-year median of 37.35. GuruFocus rates SHSE:688161 with a GF Score™ of 75/100 and a GF Value™ of ¥32.42 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 413 Medical Devices & Instruments companies, Shandong Weigao Orthopaedic Device Co ranks better than 57.38% on this metric.
SHSE:688161's EV-to-FCF is ranked better than 57.38% of 413
companies
in the Medical Devices & Instruments industry
Industry Median: 23.72
vs SHSE:688161: 19.07
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Shandong Weigao Orthopaedic Device Co (SHSE:688161) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Shandong Weigao Orthopaedic Device Co's PE Ratio (TTM) for today is calculated as:
Shandong Weigao Orthopaedic Device Co's share price for today is ¥21.82.
Shandong Weigao Orthopaedic Device Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.650.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Shandong Weigao Orthopaedic Device Co EV-to-FCF Related Terms
Shandong Weigao Orthopaedic Device Co EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Weigao Orthopaedic Device Co EV-to-FCF Chart
SHSE:688161 vs ABT, SYK, MDT: EV-to-FCF Comparison
For the Medical Devices subindustry, Shandong Weigao Orthopaedic Device Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shandong Weigao Orthopaedic Device Co EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shandong Weigao Orthopaedic Device Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Shandong Weigao Orthopaedic Device Co's EV-to-FCF falls into.
Shandong Weigao Orthopaedic Device Co's current Enterprise Value is ¥6,981 Mil.
Shandong Weigao Orthopaedic Device Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥366 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Weigao Orthopaedic Device Co (SHSE:688161) has a EV-to-FCF of 19.07 as of Jul. 17, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Shandong Weigao Orthopaedic Device Co and its competitors. This is 49% below median its historical median of 37.35. Over the past decade, Shandong Weigao Orthopaedic Device Co's EV-to-FCF has ranged from 17.30 to 214.16. According to the industry distribution chart, Shandong Weigao Orthopaedic Device Co ranks #176 out of 413 companies in the Medical Devices & Instruments industry, placing it in the top 42.6%.
Is Shandong Weigao Orthopaedic Device Co's EV-to-FCF too high?
Shandong Weigao Orthopaedic Device Co's current EV-to-FCF of 19.07 is 49% below median its 10-year median of 37.35. Over the past 10 years, this metric has ranged from a low of 17.30 to a high of 214.16. The Medical Devices & Instruments industry median EV-to-FCF is 23.72. Shandong Weigao Orthopaedic Device Co's value of 19.07 is 19.6% below this industry median. Based on the distribution chart, Shandong Weigao Orthopaedic Device Co ranks #176 out of 413 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Shandong Weigao Orthopaedic Device Co has a GF Score™ of 75/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shandong Weigao Orthopaedic Device Co's EV-to-FCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shandong Weigao Orthopaedic Device Co ranks #176 out of 413 companies for EV-to-FCF. This puts Shandong Weigao Orthopaedic Device Co in the upper half of its industry. The industry median EV-to-FCF is 23.72. Shandong Weigao Orthopaedic Device Co's value of 19.07 is 19.6% below this benchmark. Historically, Shandong Weigao Orthopaedic Device Co's own EV-to-FCF has ranged from 17.30 to 214.16 over the past decade. While the company's 10-year median is 37.35 vs. the industry median of 23.72, Shandong Weigao Orthopaedic Device Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.72, based on 413 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shandong Weigao Orthopaedic Device Co's current EV-to-FCF of 19.07 is 19.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Shandong Weigao Orthopaedic Device Co and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shandong Weigao Orthopaedic Device Co's current EV-to-FCF is 19.07, which is 49% below median its own 10-year median of 37.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Weigao Orthopaedic Device Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Weigao Orthopaedic Device Co (SHSE:688161) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥32.42, compared to a current price of ¥21.82 — trading 32.7% below its estimated fair value. The current EV-to-FCF is 19.07, which is 49% below median its 10-year median of 37.35 and 19.6% below the Medical Devices & Instruments industry median of 23.72. Shandong Weigao Orthopaedic Device Co's overall GF Score™ is 75/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Shandong Weigao Orthopaedic Device Co (SHSE:688161), the current EV-to-FCF is 19.07 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shandong Weigao Orthopaedic Device Co (SHSE:688161) Overvalued in 2026?
Based on GuruFocus' analysis, Shandong Weigao Orthopaedic Device Co stock appears to be undervalued.
The current stock price of ¥21.82 is trading 32.7% below its estimated GF Value™ of ¥32.42.
GuruFocus considers Shandong Weigao Orthopaedic Device Co to be Significantly Undervalued.
Key valuation signals for SHSE:688161:
EV-to-FCF: 19.07 (49% below median its 10-year median of 37.35)
GF Value™: ¥32.42 vs. price of ¥21.82 (32.7% below fair value)
Industry Position: 19.6% below the Medical Devices & Instruments median (#176 of 413)
No single metric tells the full story. See the SHSE:688161 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shandong Weigao Orthopaedic Device Co Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688161 has been successfully added to your 
